Back to Search
LEWIS SILVERMAN, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1306814728Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
79131(MA)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
79131(MA)330970(NY)
Research & Publications (20)
Release of gentamicin from a tricalcium phosphate bone implant.
PMID 17034052·J Orthop Res·2007
7-preclinical
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.
PMID 16921040·J Clin Oncol·2006
8-other
DNA methyltransferase inhibitors in myelodysplastic syndrome.
PMID 15494296·Best Pract Res Clin Haematol·2004
6-review
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
PMID 12011120·J Clin Oncol·2002
3-trial
Targeting hypomethylation of DNA to achieve cellular differentiation in myelodysplastic syndromes (MDS).
PMID 11700387·Oncologist·2001
6-review
Methylation inhibitor therapy in the treatment of myelodysplastic syndrome.
PMID 16341236·Nat Clin Pract Oncol·2005
6-review
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.
PMID 19672973·Pediatr Blood Cancer·2010
3-trial
"Smart Bodies" school wellness program increased children's knowledge of healthy nutrition practices and self-efficacy to consume fruit and vegetables.
PMID 19135111·Appetite·2009
4-observational
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.
PMID 19546476·Blood·2009
3-trial
Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.
PMID 19405141·Pediatr Blood Cancer·2009
4-observational
Childhood acute lymphoblastic leukemia: update on prognostic factors.
PMID 19242236·Curr Opin Pediatr·2009
6-review
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
PMID 19458356·Blood·2009
8-other
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
PMID 19167676·Biol Blood Marrow Transplant·2009
6-review
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
PMID 19230772·Lancet Oncol·2009
3-trial
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).
PMID 19025972·Cancer·2009
3-trial
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
PMID 19657114·Blood·2009
3-trial
Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242.
PMID 19552692·Br J Pharmacol·2009
4-observational
H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
PMID 18977325·Cancer Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 44 Binney St, Dana Farber Cancer Institute
Boston, MA 02115 - Phone
- (617) 632-5285
Quick Facts
- NPI
- 1306814728
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile